Phreesia Inc. Faces Securities Fraud Lawsuit Over Investor Losses
Shareholders who incurred losses in Phreesia Inc. (NYSE: PHR) have an opportunity to lead a securities fraud class action lawsuit. The complaint alleges misrepresentations regarding the company's growth outlook.
Phreesia Inc. (NYSE: PHR) is facing a securities fraud class action lawsuit, according to an announcement from law firm Glancy Prongay Wolke & Rotter LLP. The firm states that investors who suffered losses between May 8, 2025, and March 30, 2026, have the opportunity to serve as lead plaintiffs in the action.
The lawsuit alleges that Phreesia and its executives created a false impression of the company's long-term growth prospects and its confidence in revenue projections for fiscal year 2027. It claims these statements misrepresented the durability of pharmaceutical marketing commitments as a key growth driver for the Network Solutions segment.
According to the complaint, the company downplayed risks associated with slowing growth in its Network Solutions business. In reality, the reliability of these pharmaceutical marketing commitments was uncertain, potentially jeopardizing the 2027 revenue target.
The lead plaintiff deadline for the lawsuit is July 13, 2026. Glancy Prongay Wolke & Rotter LLP is actively seeking investors with losses to come forward to discuss their potential role in the litigation.